Viral Skin Diseases in the Pediatric Practice: Update on Management, Immune Response Modifiers, and Other Therapies
A supplement to Pediatric News supported by a restricted educational grant from 3M Pharmaceuticals. It is jointly sponsored by Excerpta Medica, Inc., an ACCME accredited provider, and Pediatric News.
Highlights of presentations taken from a roundtable that took place on February 7, 2003, in Chicago, Ill.
To view the supplement, click the image above. To take the CME test, download and print out the PDF file, and follow the test instructions on page 16.
Contents
• Introduction
• Cutaneous Manifestations of Viral Infections: An Overview
• Perspective on Human Papillomavirus in Children
• Herpesviruses and the Pediatric Practice
• Current Views on Molluscum Contagiosum
• Less Common Viral Exanthems of Special Interest
Faculty
Amy S. Paller, MD (Chair)
Professor of Dermatology and Pediatrics
Northwestern University Medical School
Chief, Dermatology
Children's Memorial Hospital, Chicago Consultant: 3M. Discusses the investigational use of imiquimod and cantharidin for treating molluscum contagiosum.
Lawrence F. Eichenfield, MD
Professor of Pediatrics and Medicine (Dermatology)
Chief, Pediatric and Adolescent Dermatology
Children's Hospital, San Diego
University of California, San Diego School of Medicine Discusses the investigational use of imiquimod and cantharidin for treating molluscum contagiosium.
Moise L. Levy, MD
Professor of Dermatology and Pediatrics
Baylor College of Medicine
Chief, Dermatology Service
Texas Children's Hospital, Houston Discusses the investigational use of cidofovir for treating warts and molluscum contagiosum.
Seth J. Orlow, MD, PhD
Professor of Dermatology, Cell Biology, and Pediatrics
Director of Pediatric Dermatology
New York University School of Medicine Consultant: 3M. He discusses the investigational use of cidofovir, cantharidin, tretinoin, imiquimod, acyclovir, and cimetidine for treating cutaneous viral infections in children, as well as the investigational use of garlic for treating verruca vulgaris.
Stephen K. Tyring, MD, PhD
Professor, Department of Microbiology & Immunology, Dermatology & Internal Medicine
University of Texas Medical Branch, Houston Clinical grants from and consultant to: 3M. He discusses the investigational use of imiquimod for treating non-genital warts and molluscum contagiosium.
Target Audience
This activity has been developed for pediatricians and family practice physicians who treat children and adolescents.
Educational Needs
Viral diseases may cause a number of types of mucocutaneous manifestations, the expressions of which may be confusing. It is important for clinicians to be able to identify the types of lesions most closely identified with the various diseases. However, visual inspection alone is insufficient for making a diagnosis, so familiarity with the current laboratory diagnostic methods is essential. Finally, clinicians must remain up-to-date regarding the treatment of the most common viral infections seen in children—including those caused by human papillomaviruses, herpesviruses, and poxviruses. Recent advances in clinical studies with the immune response modifier imiquimod and other therapies will be discussed.
Learning Objectives
By reading and studying this supplement, participants should be able to:
• Name the types of lesions that may be seen in viral infections, along with the most common diseases with which each is associated.
• Discuss the uses of viral cultures, microscopic examination of infected tissue, viral antigen detection, DNA and RNA detection, and serology in the diagnosis of viral diseases in general.
• Describe the current management issues in pediatric infections involving human papillomaviruses, herpesviruses, and poxviruses.
• Summarize the research findings regarding newer therapies for common viral infections in pediatrics, including the use of the immune response modifier imiquimod.
Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Excerpta Medica, Inc. and Pediatric News. Excerpta Medica is accredited by the ACCME to provide continuing medical education for physicians.
